Stephanie Nwegbo is the Founder and CEO of Aurora Pharmaceutical Consulting, bringing more than a decade of experience across pharmaceutical, biotechnology, and medical device research. Her background spans clinical monitoring, global clinical operations, study startup, CRO and vendor oversight, safety management, and inspection readiness, including work supporting a global program spanning 135 sites across 33 countries.

Through Aurora, she provides Clinical Trial Transition Management (CTTM) and clinical operations continuity services, helping sponsors navigate changes in CROs, vendors, teams, and technology. Her work focuses on preserving operational knowledge, strengthening oversight, and improving efficiency while protecting patient safety and data integrity.